For Women
Clinical Trial Information
Sebela Pharmaceuticals is undergoing Phase 2 Clinical Trials in the United States. To learn more, please visit https://clinicaltrials.gov/ct2/show/NCT02882191.
Clinical Study Title: Evaluation of the Efficacy and Safety of LevoCept
ClinicalTrials.gov Identifier: NCT02882191
CAUTION: Limited by Federal Law to Investigational Use.